Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Fierce Pharma
ASH: J&J pressures CAR-T with Tecvayli combo in 2L myeloma
The Tecvayli-Darzalex combo’s overall survival curve flattened, suggesting the potential of a cure.
Angus Liu
Dec 9, 2025 7:30am
FDA panel votes against J&J shunt implant for heart failure
Dec 5, 2025 4:31pm
Analyst deems Janux's stock spiral an 'overreaction'
Dec 2, 2025 11:14am
J&J MedTech bolsters stroke R&D programs in Ireland
Nov 24, 2025 2:20pm
J&J's anti-tau antibody posdinemab flops in phase 2
Nov 24, 2025 9:40am
Contineum-J&J drug fails to improve vision in phase 2 MS trial
Nov 20, 2025 5:26pm
